FY2024 EPS Estimates for OTCMKTS:GTBIF Decreased by Analyst

Green Thumb Industries Inc. (OTCMKTS:GTBIF) – Analysts at Ventum Cap Mkts decreased their FY2024 earnings estimates for shares of Green Thumb Industries in a research note issued on Friday, November 8th. Ventum Cap Mkts analyst A. Semple now forecasts that the company will post earnings of $0.31 per share for the year, down from their previous forecast of $0.34. Ventum Cap Mkts currently has a “Strong-Buy” rating on the stock. The consensus estimate for Green Thumb Industries’ current full-year earnings is $0.32 per share. Ventum Cap Mkts also issued estimates for Green Thumb Industries’ Q4 2024 earnings at $0.06 EPS and FY2025 earnings at $0.25 EPS.

Separately, Craig Hallum upgraded shares of Green Thumb Industries to a “strong-buy” rating in a report on Monday, September 16th. Three equities research analysts have rated the stock with a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat.com, Green Thumb Industries has an average rating of “Buy” and a consensus price target of $16.50.

Green Thumb Industries Price Performance

Shares of OTCMKTS:GTBIF opened at $7.80 on Monday. The business’s 50-day moving average is $10.26 and its 200 day moving average is $11.14. Green Thumb Industries has a 1 year low of $7.50 and a 1 year high of $16.33. The firm has a market capitalization of $1.65 billion, a P/E ratio of 28.90 and a beta of 1.40.

Green Thumb Industries (OTCMKTS:GTBIF) last issued its quarterly earnings results on Thursday, November 7th. The company reported $0.04 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.06 by ($0.02). The business had revenue of $286.87 million for the quarter, compared to analyst estimates of $283.96 million. Green Thumb Industries had a return on equity of 3.39% and a net margin of 5.38%.

About Green Thumb Industries

Green Thumb Industries Inc manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States. It operates through two segments, Retail and Consumer Packaged Goods. The company offers cannabis flower; processed and packaged products, including pre-rolls, concentrates, vapes, capsules, tinctures, edibles, topicals, and other cannabis-related products under the &Shine, Beboe, Dogwalkers, Doctor Solomon's, Good Green, incredibles, and RHYTHM brands.